查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566792

真皮填充剂市场：按类型、性别、服务供应商：2024-2033 年全球机会分析与产业预测

Dermal Filler Market By Type (Hyaluronic acid , Calcium Hydroxylapatite , Poly L lactic Acid, Others), By Gender By Service Provider : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

真皮填充剂市场

2023 年真皮填充剂市值为 63 亿美元，预计 2024 年至 2033 年复合年增长率为 10.3%，到 2033 年将达到 168 亿美元。

真皮填充剂是一种凝胶状物质，注入皮肤可恢復体积、抚平细纹和皱纹，并增强脸部轮廓。注射真皮填充剂是一种非手术过程，可立即见效，可持续数月至数年，具体取决于注射的填充剂类型。透明质酸是用于滋润和丰盈皮肤的真皮填充剂中最常见的成分。除了合成填充剂之外，还有天然形式的真皮填充剂，其中将从人类的其他身体部位采集的脂肪注射到所需的身体部位。这个过程被称为自体脂肪移植。

老化症状的早期出现是真皮填充剂市场的关键驱动因素之一。此外，由于社群媒体的影响，个人，尤其是女性的美学意识不断增强，也推动了对真皮填充剂的需求。最近，生物刺激填充剂因其刺激体内天然胶原蛋白的产生而受到人们的欢迎。这些填充剂是化学填充剂无法比拟的，因为它们可以促进人体的自然再生过程。

然而，注射真皮填充剂的成本相当高，导致许多人无法利用其益处。此外，术后併发症和副作用对某些人来说非常有害，因此使得某些人不愿意进行此类注射。儘管有潜在的副作用，但真皮填充剂的病例每年都在增加。国际美容整形外科学会进行了一项研究，以确定2023年全球手术和非手术整容手术的统计数据。研究显示，到 2023 年，透明质酸填充病例将增加 29%，使真皮填充病例成为美国最大的病例。

分部审查

全球皮肤填充剂市场按类型、性别、服务供应商和地区细分。依类型划分，市场分为透明质酸（HA）、羟基磷灰石钙（CaHA）、聚-L-乳酸等。从性别上来说，分为男性和女性。依服务供应商分类，可分为专科/皮肤科诊所、医院等。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按类型划分，透明质酸 (HA) 细分市场 2023 年的市场收益最高。

从性别来看，2023 年女性族群在真皮填充剂市场占据主导地位。

按服务供应商，医院部门是 2023 年最大的相关人员。

按地区划分，北美地区 2023 年收益最高。

可以自订此报告（需要额外的费用和时间表）

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料
  • 主要参与企业的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章真皮填充剂市场：依类型

  • 市场概况
  • 透明质酸（HA）
    • 年龄组
      • 13-39岁
      • 40-54岁
      • 55-69岁
  • 羟磷石灰钙 (CaHA)
  • 聚L乳酸
  • 其他的

第五章真皮填充材市场：性别

  • 市场概况
  • 男性
  • 女士

第六章真皮填充剂市场：依服务供应商分类

  • 市场概况
  • 专科诊所和皮肤科诊所
  • 医院
  • 其他的

第七章真皮填充剂市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国真皮填充剂市场
    • 加拿大真皮填充剂市场
    • 墨西哥真皮填充剂市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国真皮填充剂市场
    • 法国真皮填充剂市场
    • 英国真皮填充剂市场
    • 义大利真皮填充剂市场
    • 西班牙真皮填充剂市场
    • 其他欧洲真皮填充剂市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本真皮填充剂市场
    • 中国真皮填充剂市场
    • 印度真皮填充剂市场
    • 澳洲真皮填充剂市场
    • 韩国真皮填充剂市场
    • 其他亚太地区真皮填充剂市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西真皮填充剂市场
    • 沙乌地阿拉伯真皮填充剂市场
    • 南非真皮填充剂市场
    • 其他拉丁美洲/中东/非洲真皮填充剂市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Teoxane Laboratories
  • Cutera Inc
  • Elan Aesthetics Inc
  • Bioxis Pharmaceutical
  • AbbVie Laboratories
  • Sinclair Pharma
  • Sosum Global
  • Revance Therapeutics
  • Galderma SA
  • Merz Pharma
简介目录
Product Code: A07289

Dermal Filler Market

The dermal filler market was valued at $6.3 billion in 2023, and is projected to reach $16.8 billion by 2033, growing at a CAGR of 10.3% from 2024 to 2033.

Dermal filler is a gel-like substance injected into the skin to restore its volume, smooth out its lines & wrinkles, and enhance the contours of the face. The injection of derma fillers is a non-surgical process which shows instant results and lasts for a few months to years, depending on the type of filler injected. Hyaluronic acid is the most common component of derma fillers used to hydrate and volumize the skin. Apart from synthetic fillers, there is a natural form of derma filler where fat from some other body part of a person is injected into the target body part. This process is known by the term - autologous fat grafting.

Rise in occurrence of ageing symptoms at an early stage is one of the major drivers of the dermal filler market. Moreover, increase in aesthetic awareness among individuals, particular females, due the influence of social media is boosting the demand for dermal fillers. In recent times, biostimulatory fillers are acquiring traction among individuals as they promote the production of natural collagen in the body. These fillers promote the natural regenerative process inside the body, hence are not comparable to chemical fillers.

However, the expenses of administering dermal filler injections are significantly high, which prevent a large population from availing the benefits. In addition, the post-procedure complications and side-effects are highly adverse in some individuals, hence making several individuals reluctant about administering such injections. Despite the chances of side effects, the cases of dermal fillers are increasing every year. The International Society of Aesthetic Plastic Surgery conducted a survey in 2023 to determine the statistics of surgical and non-surgical cosmetic procedures around the globe. According to this survey, named, International Survey on Aesthetic/Cosmetic Procedures, the cases of hyaluronic acid fillers upsurged by 29% in 2023, with maximum derma filler cases occurring in the U.S.

Segment Review

The global dermal filler market is segmented into type, gender, service provider, and region. On the basis of type, the market is divided into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly L lactic acid, and others. By gender, it is bifurcated into male and female. Depending on service provider, it is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the hyaluronic acid (HA) segment generated the largest revenue in the market in 2023.

By gender, the female segment dominated the dermal fillers market in 2023.

Depending on service provider, the hospitals segment was the largest stakeholder in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players operating in the global dermal filler market are Teoxane Laboratories, Cutera Inc, Elan aesthetics Inc, Bioxis pharmaceutical, AbbVie Laboratories, Sinclair Pharma, Sosum Global, Revance Therapeutics, Galderma SA, and Merz Pharma. These players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Hyaluronic acid (HA)
    • Age group

◦ 13 to 39

◦ 40 to 54

◦ 55 to 69

  • Calcium Hydroxylapatite (CaHA)
  • Poly L lactic Acid
  • Others

By Gender

  • Male
  • Female

By Service Provider

  • Specialty and Dermatology Clinics
  • Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Teoxane Laboratories
    • Cutera Inc
    • Elan aesthetics Inc
    • Bioxis pharmaceutical
    • AbbVie Laboratories
    • Sinclair Pharma
    • Sosum Global
    • Revance Therapeutics
    • Galderma SA
    • Merz Pharma

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: DERMAL FILLER MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Hyaluronic Acid (HA)
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
    • 4.2.5. Age group
      • 4.2.5.1. Market Size and Forecast
      • 4.2.5.2. 13 to 39
      • 4.2.5.2.1. Market Size and Forecast
      • 4.2.5.2. 40 to 54
      • 4.2.5.2.1. Market Size and Forecast
      • 4.2.5.2. 55 to 69
      • 4.2.5.2.1. Market Size and Forecast
  • 4.3. Calcium Hydroxylapatite (CaHA)
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Poly L Lactic Acid
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Others
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: DERMAL FILLER MARKET, BY GENDER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Gender
  • 5.2. Male
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Female
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: DERMAL FILLER MARKET, BY SERVICE PROVIDER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Service Provider
  • 6.2. Specialty And Dermatology Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Hospitals
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: DERMAL FILLER MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Gender
    • 7.2.4. Market Size and Forecast, By Service Provider
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Dermal Filler Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Gender
      • 7.2.6.3. Market Size and Forecast, By Service Provider
    • 7.2.7. Canada Dermal Filler Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Gender
      • 7.2.7.3. Market Size and Forecast, By Service Provider
    • 7.2.8. Mexico Dermal Filler Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Gender
      • 7.2.8.3. Market Size and Forecast, By Service Provider
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Gender
    • 7.3.4. Market Size and Forecast, By Service Provider
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Dermal Filler Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Gender
      • 7.3.6.3. Market Size and Forecast, By Service Provider
    • 7.3.7. France Dermal Filler Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Gender
      • 7.3.7.3. Market Size and Forecast, By Service Provider
    • 7.3.8. UK Dermal Filler Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Gender
      • 7.3.8.3. Market Size and Forecast, By Service Provider
    • 7.3.9. Italy Dermal Filler Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Gender
      • 7.3.9.3. Market Size and Forecast, By Service Provider
    • 7.3.10. Spain Dermal Filler Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Gender
      • 7.3.10.3. Market Size and Forecast, By Service Provider
    • 7.3.11. Rest of Europe Dermal Filler Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Gender
      • 7.3.11.3. Market Size and Forecast, By Service Provider
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Gender
    • 7.4.4. Market Size and Forecast, By Service Provider
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Dermal Filler Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Gender
      • 7.4.6.3. Market Size and Forecast, By Service Provider
    • 7.4.7. China Dermal Filler Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Gender
      • 7.4.7.3. Market Size and Forecast, By Service Provider
    • 7.4.8. India Dermal Filler Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Gender
      • 7.4.8.3. Market Size and Forecast, By Service Provider
    • 7.4.9. Australia Dermal Filler Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Gender
      • 7.4.9.3. Market Size and Forecast, By Service Provider
    • 7.4.10. South Korea Dermal Filler Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Gender
      • 7.4.10.3. Market Size and Forecast, By Service Provider
    • 7.4.11. Rest of Asia-Pacific Dermal Filler Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Gender
      • 7.4.11.3. Market Size and Forecast, By Service Provider
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Gender
    • 7.5.4. Market Size and Forecast, By Service Provider
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Dermal Filler Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Gender
      • 7.5.6.3. Market Size and Forecast, By Service Provider
    • 7.5.7. Saudi Arabia Dermal Filler Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Gender
      • 7.5.7.3. Market Size and Forecast, By Service Provider
    • 7.5.8. South Africa Dermal Filler Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Gender
      • 7.5.8.3. Market Size and Forecast, By Service Provider
    • 7.5.9. Rest of LAMEA Dermal Filler Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Gender
      • 7.5.9.3. Market Size and Forecast, By Service Provider

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Teoxane Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Cutera Inc
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Elan Aesthetics Inc
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Bioxis Pharmaceutical
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. AbbVie Laboratories
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Sinclair Pharma
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Sosum Global
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Revance Therapeutics
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Galderma SA
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Merz Pharma
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments